Title |
Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity
|
---|---|
Published in |
Clinical Research in Cardiology, January 2012
|
DOI | 10.1007/s00392-011-0411-3 |
Pubmed ID | |
Authors |
Thomas Gremmel, Karin Frühwirth, Christoph W. Kopp, Alexandra Kaider, Sabine Steiner, Tamam Bakchoul, Ulrich J. H. Sachs, Renate Koppensteiner, Simon Panzer |
Abstract |
The frequency of heparin-induced platelet antibodies (H/PF4 antibodies) following heparin exposure during percutaneous intervention with stent implantation is unknown. These antibodies may activate platelets and therefore contribute to high on-clopidogrel residual platelet reactivity (HRPR). |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 13 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 46% |
Student > Ph. D. Student | 2 | 15% |
Other | 1 | 8% |
Student > Doctoral Student | 1 | 8% |
Professor | 1 | 8% |
Other | 2 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 54% |
Immunology and Microbiology | 2 | 15% |
Biochemistry, Genetics and Molecular Biology | 1 | 8% |
Agricultural and Biological Sciences | 1 | 8% |
Unknown | 2 | 15% |